科学网

 找回密码
  注册

tag 标签: Lancet

相关帖子

版块 作者 回复/查看 最后发表

没有相关内容

相关日志

中国的老龄化:一个定时炸弹(Lancet社论)
热度 48 yanjx45 2016-11-2 11:01
中国的老龄化:一个定时炸弹 ( Ageing in China: a ticking bomb ) Lancet 388 ( 10056 ): 2058, 2016 ( 29 October ) 孝道在中国文化中被认为是一种重要的美德,是保护和支持中国老年人的社会保健系统的基石。然而 目前在 中国,为老年人提供照顾的牢固的家庭结构正在逐渐崩溃,起因是大规模的城镇化、经济的快速增长、生育率的降低以及较小的家庭规模。 同时, 中国是世界上老龄化速度最快的国家之一,年龄在 65 岁及以上的老年人口比世界上任何其他国家都更多,并且在到达 2050 年时,全国总人口中老年人的比例预计将达 25% 左右。 在中国,老年人的健康需求对国家的卫生和社会保障系统提出了空前严重的挑战。根据 10 月 19 日发布的 2015 年中国退休人员健康问题纵向研究报告 , 中国年龄在 60 岁或以上的老年人中三分之一的人有严重的抑郁症,高血压、糖尿病的患病率在这一群体中分别为 53. 6% 和 23.9% 。 此外 , 在中国每年有 50 万老年人会走失方向,其中大约有 25% 被诊断为阿尔茨海默氏症或老年痴呆症, 72% 患有记忆障碍。 这样惊人的结果是由中国民政部所属的中民社会救助研究所公布的最新报告揭示的。 为有效促进老龄政策和方案的制定, 10 月 17-19 日在上海召开了 哥伦比亚 - 复旦大学全球老龄化与健康峰会 ( The Columbia-Fudan Global Summit on Aging Health ) ,主题是关于研究、政策、卫生系统和行业举措的对话( A Dialogue on Research,Policy, Health Systems and Industry Initiatives )。会议主张 重视“第三人口红利( third demographic dividend )”,充分利用老年人的社会资本,奔向更强大和更富裕的社会,让年轻人获得更大的成功,让最年老的人获得更大的支持。 对于中国老年人的照顾不可能再主要依靠家庭,因此迫切需要有社会和政治的变革以适应人口统计学上的迅速变化。 老龄人口不应被视为经济的消耗和年轻一代的包袱。积极应对人口老龄化将促进中国的卫生和社会保健系统的改革和完善。 (资料来源: http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(16)32058-X.pdf )
个人分类: 社会科学|11978 次阅读|197 个评论
[转载]The Lancet:降钙素原或可成为抗菌药物停药指征
fqng1008 2016-3-15 16:58
2016 年 3 月 2 日,荷兰阿姆斯特丹自由大学的 de Jong 博士及其同事在 The Lancet 上发表了关于降钙素原指导停药研究( SAPS )的研究成果。该研究旨在评估降钙素原在减少抗菌药物使用时间上的有效性和安全性。 The Lancet 对此发表了评论,认为成果可写入指南并应用于临床。 抗菌药物滥用导致多重耐药菌的出现,正威胁着公共健康。为解决这一问题,必须着眼于抗菌药物管理方案的实施,限制抗菌药物的使用,避免长程治疗。除了临床参数,监测血清标记物 —— 降钙素原可使治疗方案个体化,以对抗全身细菌感染。 降钙素原可在微生物毒素和促炎介质作用下上升,在感染恢复时下降。其测得值与菌血症和感染的严重程度高度相关。持续处于特定浓度点提示治疗方案不成功,故降钙素原动力学具有指导预后的意义。 由于降钙素原存在一些不足,故最新版的「拯救脓毒症运动」指南对降钙素原的使用仅作弱推荐( Grade 2C ),即「建议当未发现感染证据时,低降钙素原用于停止经验性抗菌药物的使用」。因此,需要一个大型完美的试验提供终极证据证明,降钙素原可指导抗菌药的管理,且用于重症患者时可切实减少发病率和病死率。 APS 试验是目前最大的降钙素原指导研究。共招募了 1546 个疑似或确诊的重症患者,分别来自 3 个大学医学中心和 12 个荷兰教学医院。 降钙素原指导组( 761 位患者)定为降钙素原较峰值减少 80% 及以上或降至 0.5 μ g/L 及以下时则停止使用抗菌药,另一组( 785 位患者)则是基于常规治疗方案。而且,需要注意的是,相对于其他高收入国家,荷兰的常规治疗对于抗微生物药物的使用是非常谨慎的。 APS 试验对未来患者的治疗具有非常重要的影响。首先,研究证实了之前治疗重症患者措施的正确性,减少长程抗感染治疗。其次,扩大了研究范围,从呼吸道感染扩展到更广泛的一般疑似感染的重症患者群体。第三,降钙素原指导组较常规治疗组的病死率有所下降。显然,降钙素原可提高诊断率,并使治疗决策更有效。同时,也减少了使用抗菌药物带来的副作用。 总而言之,脓毒症是一个复杂、表现多样的综合征,而降钙素原监测的准确率远非完美。因此,临床医生的经验和判断一直是任何抗感染管理方案所必须的重要组成部分。 APS 试验说服了那些曾经质疑降钙素原指导停药的批评者。此外,通过监测降钙素原,早期停用抗菌药,对抗感染策略进行个体化治疗,最终可使终末期患者获益,甚至存活。在临床实践中,应逐步广泛开展此类方法,以延缓耐药菌的出现和减慢抗菌药物研发崩溃速度,并由此寻求最佳的诊疗方案。
个人分类: 临床研习|1215 次阅读|0 个评论
Lancet:一种对全球构成威胁的新病毒:寨卡(Zika)病毒
热度 21 yanjx45 2016-1-10 11:34
寨卡(Zika)病毒是一种新出现的由蚊子传播的虫媒病毒,近期在中美洲和南美洲引起新的爆发流行。估计目前仅在巴西就有44万– 130万病例。巴西卫生部1月5日报告称,巴西因寨卡病毒所致的疑 似新生儿小头畸形症病例已达3174例,其中已有38名畸形婴儿死亡。医学专家认为,巴西小头畸形病例激增与寨卡病毒直接相关。该病毒侵入胎盘,影响胎儿大脑生长。新生儿头颅过小,将导致身体及智力发育落后。 寨卡( Zika )病毒: 2016 年对全球的一个新威胁 Lancet 社论: Zika virus: a new global threat for 2016 据报道,寨卡( Zika )病毒在中美洲和南美洲引起新的爆发流行,关于该病毒对全球卫生安全造成威胁的担忧正不断升级。现在已在哥伦比亚、萨尔瓦多、危地马拉、墨西哥、巴拉圭、波多黎各和委内瑞拉检测到寨卡病毒在本地传播的病例。在苏里南检测到的第一批本地传播的 5 个病例的报告已在网上公布,包括来自一个病人的病毒的完整编码序列,以及来自另外 3 个病人的病毒包膜蛋白编码序列。系统发生分析表明,苏里南毒株属于亚洲基因型,并与 2013 年流行在法属波利尼西亚的毒株密切相关。 上个月,巴西卫生部报告,在该国东北地区新生儿小头畸形病例出现 20 倍的年度增长。在这些具有小头畸形的婴儿中有 3 个在 眼部检查时发现 黄斑区眼底发生了变化。母亲体内的寨卡病毒和新生儿小头畸形之间的因果关系还有待进一步确认,但这种令人担忧的可能性是很大的。其它先天性神经异常和格林 - 巴利综合征发生频率的增加与寨卡病毒的相关性也曾有过报道。 寨卡病毒是一种新出现的由蚊子传播的虫媒病毒,该病毒于 1947 年首次在乌干达从一只恒河猴分离到,它在一些非洲和亚洲国家造成零星的人类感染,通常引起发热、皮疹、关节痛等轻微症状。在 2007 年,它在密克罗尼西亚联邦的 Yap 岛曾引发一次流行,随后蔓延到大洋洲的许多国家,在 2014-15 年传播到美洲(可能是经由复活节岛)。 估计目前仅在巴西就有 44万 – 1 30万 病例,寨卡病毒可能伴随登革热和基孔肯雅热发生,后两者也都是由 埃及伊蚊 ( Aedes aegypti )传播 的。鉴于寨卡病毒在任何地方的爆发都可能是对所有地方的威胁,现在是对寨卡病毒加强预防、检测和作出反应的时候了。 Lancet 2014; 383: 764–66 原文链接: http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(16)00014-3.pdf
个人分类: 科学普及|10373 次阅读|47 个评论
[转载]中山大学附属第一医院研究成果发表于《Lancet Oncology》
deafudiu 2013-12-15 13:08
中山大学附属第一医院转化医学研究成果发表于《Lancet Oncology》 日前,由中山大学附属第一医院转化医学中心罗俊航副教授和中山大学肿瘤医院谢丹教授牵头联合中山大学附属第一医院、中山大学肿瘤医院等多家研究团队关于microRNA在Ⅱ期结肠癌中的预后和预测价值的转化医学研究成果发表于最新一期《Lancet Oncology》(2013,14:1295-1306; IF=25.1)。 NCCN指南建议Ⅱ期结肠癌的高危患者手术后应行辅助化疗。但国外24,847例的大样本量回顾性研究表明Ⅱ期结肠癌高危患者不能从辅助化疗中获益。针对上述矛盾,中山一院联合广东省多家研究团队在国家自然科学基金资助下探索应用转化医学解决临床实际问题。结果表明,真正的Ⅱ期高危患者是可以从辅助化疗中获益的,先前的报道之所以得出相悖的结论是因为NCCN指南定义Ⅱ期高危患者的指征过于宽泛,按照这一标准有65%-75%的Ⅱ期结肠癌患者是高危患者,其实真正死于结肠癌的Ⅱ期患者只有约25%,也就是说Ⅱ期结肠癌患者中有40%-50%的患者是“被”高危的,把大量的“被”高危的患者纳入辅助化疗观察人群导致信息干扰,没能统计出真正的获益群体。 该研究通过芯片筛查获得的6个miRNA检测结果结合NCCN指南的4个高危指标,可以使Ⅱ期结肠癌患者“被”高危的风险减低20%以上。同时该研究也指出目前的研究结果仍存在以下不足:首先,这是一项回顾性研究,结果说服力不如前瞻性研究;其次,这是华南地区几家医院的合作研究且样本量较小,欠缺广泛的代表性。这些初步结果有待更广泛的多中心性前瞻研究进行验证。
2460 次阅读|0 个评论
[转载]The LANCET: China—a call for papers
csichina 2012-3-7 17:24
The Lancet, Volume 379, Issue 9818 , Page 787, 3 March 2012 Francis Chan a , Jin Ling Tang a , Sian Griffiths a , Joseph Sung a , Michael R Phillips b c , Helena Wang d Health-care reform in China remains high on the political agenda as moves are made to develop the role of primary care and improve the quality of care. 1 Whilst good progress is being made, 2 large discrepancies still exist between standards of care in rural and urban areas of China. Recognised challenges include the need for investment in community-based care, a shortage of appropriately trained health-care workers, and the promotion of evidence-based prescribing practice and control of prescribing. The Lancet continues to support clinical researchers and health professionals in China, and today publishes its latest issue themed around China's health-care reform and clinical research. The Lancet 's 2013 China themed issue will provide a further opportunity to present some of the outstanding public health and clinical research being carried out in China, and review progress on implementation of the health-care reform programme. The 2013 China issue will be published to coincide with a symposium to be held in Hong Kong in June, 2013 as part of the fiftieth anniversary of the Chinese University of Hong Kong. In addition to advances in clinical practice, major themes including food safety, migration, and the effect of social policies on people's livelihood will be addressed. We invite submissions of high-quality research from China or from research teams working on health in China. Priority will be given to reports of randomised trials that advance the evidence-base of prevention and clinical treatment of disease, and to articles about research on health-system evaluation. Reports on progress in tackling non-communicable diseases, as well as improving care for the elderly, will be welcome. Other studies that have the potential to change clinical and public health practice in China and other countries in the region are also welcome. Please submit manuscripts online before Nov 22, 2012, and mention in your cover letter that the submission is in response to this call for papers. a Chinese University of Hong Kong, Hong Kong, China b Suicide Research and Prevention Centre, Shanghai Mental Health Centre, Shanghai Jiaotong University School of Medicine, Shanghai Jiaotong University, Shanghai, China c Global Health Institute, Emory University, Atlanta, GA, USA d The Lancet, Beijing 100738, China References 1 Liu Q , Wang B , Kong Y , Cheng KK . China's primary health care reform . Lancet 2011 ; 377 : 2064-2066 . Full Text | PDF(531KB) | CrossRef | PubMed 2 Yip WC-M , Hsiao W , Chen W , Hu S , Ma J , Maynard A . Early appraisal of China's huge and complex health-care reforms . Lancet 2012 ; 379 : 833-842 . Summary | Full Text | PDF(162KB) | CrossRef | PubMed
4072 次阅读|0 个评论
中国在《柳叶刀 Lancet》论文分布(78篇 1987 - 2010年)
xupeiyang 2010-11-19 10:01
http://www.gopubmed.org/web/gopubmed/1?WEB014e6m3o22qzazI26I49I0 78 documents semantically analyzed Top Years Publications 2008 25 2010 12 2007 7 2009 5 2005 5 2003 5 2004 4 2006 3 2002 3 1997 3 1998 1 1994 1 1995 1 1987 1 1990 1 1991 1 Top Countries Publications China 78 Switzerland 3 United Kingdom 1 Top Cities Publications Beijing, China 40 Shanghai, China 7 Laizhou 6 Xi'an 4 Guangzhou 4 Nanjing 3 Geneva 3 Wuhan 2 Kunming 2 Changping 2 Shantou 2 Hangzhou 2 Liverpool 1 Changsha 1 Dalian 1 Anyang 1 rmqi 1 Top Journals Publications Lancet 78 1 2 3 ... 38 Top Terms Publications Humans 77 China 53 Adult 34 Middle Aged 21 Aged 15 Child 15 Adolescent 13 Patients 12 Health Care Reform 11 Prevalence 11 Asian Continental Ancestry Group 10 Disease Outbreaks 10 Women 9 Public Health 9 Child, Preschool 9 Delivery of Health Care 8 antigen binding 8 Men 7 Antibodies 7 Rural Health 7 1 2 3 ... 38 1 2 3 ... 25 Top Authors Publications Phillips M 3 Gao Z 2 Zhang Y 2 Guan Y 2 Yang G 2 Li S 2 Hui S 1 Yu X 1 Huang Y 1 Qu G 1 Xu J 1 Ke Y 1 Xu D 1 Sun B 1 Wan X 1 Tang S 1 Guo Y 1 Shibuya K 1 Cheng G 1 Rao K 1 1 2 3 ... 25
个人分类: 信息分析|3343 次阅读|0 个评论
爱思唯尔(Elsevier)出版公司最小气
XUPEIYANG 2010-9-18 10:25
荷兰 爱思唯尔 (Elsevier)出版 公司 最小气啦,世界四大医学名刊,就《柳叶刀》》(The Lancet)医学杂志没有免费开放。 全部免费医学期刊见 http://www.freemedicaljournals.com/index.htm#top 1. New England Journal of Medicine English ISSN: 0028-4793 EISSN: 1533-4406 FMJ Impact: 45,138 ISI Impact Factor: 47.050 Free after 6 months 1993-present Certain sections are free after 6 months. 3. JAMA: Journal of the American Medical Association English ISSN: 0098-7484 EISSN: 1538-3598 FMJ Impact: 23,399 ISI Impact Factor: 28.899 Free after 6 months 1883-present Certain sections are free after 6 months. 4. BMJ (British Medical Journal) English ISSN: 0959-8154 EISSN: 1468-5833 FMJ Impact: 15,612 ISI Impact Factor: 12.827 Free after 36 months 1988-present Title was 'British Medical Journal (Clinical research ed.)' until 1987. Free access to all articles prior to 2006. A one-time registration needs to be completed to access the archive, here: http://journals.bmj.com/cgi/register
个人分类: 开放获取|4935 次阅读|0 个评论
[转载]The Lancet Conference on Women's Health in Asia
xupeiyang 2010-8-25 07:21
E-news 02 | http://conferences.thelancet.com/womens-health-asia With the theme of Cutting edge clinical updates in obstetrics and gynaecology, The Lancet Conference on Women's Health in Asia will bring together world-leading experts to review the latest research and to debate the most effective strategies for improved sexual health and the diagnosis, treatment, and management of disorders affecting women. Presentations will include: Development of ART in China - Jie Qiao, Peking University Hospital, China Polycystic ovary syndrome - what perspective matters? - Robert Norman, University of Adelaide, Australia Medical abortion in the first trimester - Pak Chung Ho, University of Hong Kong, China Emergency contraception - Linan Cheng, Shanghai Institute of Planned Parenthood Research, China Postpartum depression - Shi Wu Wen, University of Ottawa Faculty of Medicine, Canada Gestational diabetes - Oded Langer, St. Luke's-Roosevelt Hospital Center, USA Pelvic organ prolapse - what is it? - J Eric Jelovsek, Cleveland Clinic, USA Reconstructive pelvic surgery - Lan Zhu, Peking Union Medical College Hospital, China Climacteric differences in Asians and Chinese women - Suzanne Ho, University of Hong Kong, China Endometrial cancer: diagnosis and new treatment - Noriaki Sakuragi, Hokkaido University, Japan Role of HPV testing in cervical cancer screening - Hextan Ngan, University of Hong Kong, Queen Mary Hospital Laparscopic radical hysterectomy for cervical cancer - Allan Covens, Sunnybrook Health Sciences Center Intimate partner violence - Agnes Tiwari, University of Hong Kong Early bird registration NOW OPEN! Register at: http://conferences.thelancet.com/womens-health-asia/content/registration For the full programme visit the conference website at: http://conferences.thelancet.com/wha/content/programme-overview Organised by: Co-organised by: In collaboration with: Supported by:
个人分类: 女性健康|2600 次阅读|0 个评论
柳叶刀医学杂志(Lancet)的计量分析 1999-2008
xupeiyang 2010-4-17 16:59
详细信息见 http://www.scimagojr.com/journalsearch.php?q=16590tip=sidclean=0 Lancet Country : United Kingdom Subject Area : Medicine Subject Category : Medicine (miscellaneous) Publisher : The Lancet Publishing Group . Publication type : Journals. ISSN : 01406736, 1474547X Coverage: 1823-2009 H Index : 375 Scope: The Lancet is the world leading independent general medical journal. The journal coverage is international in focus and extends to The Lancet is the world leading independent general medical journal. The journal coverage is international in focus and extends to all aspects of human health. The Lancet is published weekly from editorial offices in London and New York. It aims to publish the best original primary research papers, and review articles of the highest standard. The Lancet is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. Drawing on an international network of advisers and contributors, The Lancet meets the needs of physicians by adding to their clinical knowledge and alerting them to current issues affecting the practise of medicine worldwide. ( source ) Show full scope Charts Data SJR indicator vs. Cites per Doc (2y) // The SJR indicator measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is. Cites per Doc. (2y) measures the scientific impact of an average article published in the journal, it is computed using the same formula that journal impact factor (Thomson Reuters). Citation vs. Self-Citation // Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years. Cites per Document vs. External Cites per Document // Evolution of the number of total cites per document and external cites per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. Cites per Document in 2, 3 and 4 years windows // Evolution of Citations per Document to a journal's published documents during the two, three and four previous years. The two years line is equivalent to journal impact factor (Thomson Reuters) metric. International Collaboration // International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by researchers from more than one country. Journal's Citable vs. Non Citable Documents // Not every article in a journal is considered primary research and therefore citable, this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers, reviews and short reviews) in three years windows. Journal's Cited vs. Uncited Documents // Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year. Indicators 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 SJR 0,780 0,859 0,997 0,982 1,080 1,363 1,630 1,720 1,576 1,587 Total Documents 2.894 2.683 2.750 2.337 2.259 1.924 1.624 1.794 1.684 1.647 Total Docs. (3years) 8.195 8.301 8.440 8.327 7.770 7.346 6.520 5.807 5.342 5.102 Total References 21.272 18.334 18.343 20.061 23.598 24.338 23.697 25.842 27.325 24.570 Total Cites (3years) 25.926 33.033 37.270 35.311 35.765 38.311 39.846 38.704 33.620 32.490 Self Cites (3years) 538 490 687 664 612 635 690 802 808 836 Citable Docs. (3years) 2.824 3.405 3.592 3.531 3.270 3.274 2.903 2.518 2.289 2.240 Cites / Doc. (4years) 9,18 10,08 10,70 9,90 10,74 11,69 12,49 14,76 13,98 14,07 Cites / Doc. (3years) 9,18 9,70 10,38 10,00 10,94 11,70 13,73 15,37 14,69 14,50 Cites / Doc. (2years) 8,39 8,83 10,45 9,75 10,32 12,76 13,67 16,39 15,20 11,88 References / Doc. 7,35 6,83 6,67 8,58 10,45 12,65 14,59 14,40 16,23 14,92 Cited Docs. 3.781 4.084 4.207 4.063 3.619 3.337 3.054 2.847 2.513 2.368 Uncited Docs. 4.414 4.217 4.233 4.264 4.151 4.009 3.466 2.960 2.829 2.734 % International Collaboration 6,84 11,29 17,78 21,91 19,34 20,74 23,03 19,12 22,33 22,34
个人分类: 信息分析|1654 次阅读|0 个评论
Lancet向中国征稿 (Lancet call for research papers from Chin
baoyu 2009-4-27 21:10
最近一期的Lancet杂志向中国征稿,征稿截止到2009.9. 文中说这个专题将在2010.4.中华医学会大会时刊出,主题是中国的医疗改革实践。 大家冲击一下,Lancet可是25分的牛刊呢。 英文原文如下: Copyright 2009 Elsevier Ltd All rights reserved. Comment A call for research papers from China Lincoln Chen a , Richard Horton b and William Summerskill b a China Medical Board, Cambridge, MA, USA b The Lancet , London NW1 7BY, UK Available online 16 April 2009. Refersto: Launch of the health-care reform plan in China The Lancet , Volume 373, Issue 9672 , 18 April 2009-24 April 2009 , Pages 1322-1324 , Zhu Chen PDF (54 K) Referredtoby: Launch of the health-care reform plan in China The Lancet , Volume 373, Issue 9672 , 18 April 2009-24 April 2009 , Pages 1322-1324 , Zhu Chen PDF (54 K) Article Outline References The Comment, in The Lancet today, on health-care reform in China by Chen Zhu, the Minister of Health in China, 1 confirms the country's serious efforts towards quality-assured, affordable, and accessible health for all. 2 The extent to which these promises can be fulfilled in view of the current global financial crisis will be a critical test of China's economic stability. In 2006, President Hu Jintao emphasised the importance of scientific and technological advances to make China one of the world's most innovative countries. 3 Such innovation and commitment to research play a crucial role in guiding, implementing, and evaluating health reforms. The dedication to public health will be judged by the leadership shown in tobacco control, and the opportunities for cooperation across Ministries to reverse China's smoking epidemic. 4 Meanwhile the commitment to excellence in health care will be assessed by the extent of support for academic research. The Lancet will follow these events and others as we pre pare a themed issue on health care in China to examine progress after our Series in 2008 on health-system reform in that country. 5 The issue will be published to coincide with a conference organised by the China Medical Board in Bejing in April, 2010 . For the issue, we seek submissions of original research from China or from research teams collaborating with colleagues in China. Priority will be given to studies that will inform practice not only in China, but also in similar settings elsewhere. Please submit manuscripts online before Oct 9, 2009 and mention in your cover letter that the submission is in response to this call for papers. LC declares that he has no conflicts of interest. References 1 Z Chen, Launch of the health-care reform plan in China, Lancet 373 (2009), pp. 1322–1324. Article | PDF (54 K) 2 The Lancet, China unveils plans for health-care reform, Lancet 372 (2008), p. 1608. 3 J Wilsdon and J Keeley, China: The next science superpower? , Demos, London (2007). 4 G Yang, L Kong and W Zhao, Emergence of chronic non-communicable diseases in China, Lancet 372 (2008), pp. 1697–1705. Article | PDF (203 K) | View Record in Scopus | Cited By in Scopus (3) 5 Q Han, L Chen, T Evans and R Horton, China and global health, Lancet 372 (2008), pp. 1439–1441. Article | PDF (60 K) | View Record in Scopus | Cited By in Scopus (1)
个人分类: 生物医学|5305 次阅读|0 个评论

Archiver|手机版|科学网 ( 京ICP备07017567号-12 )

GMT+8, 2024-5-10 10:35

Powered by ScienceNet.cn

Copyright © 2007- 中国科学报社

返回顶部